to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Microsatellite instability in endometrial cancer: New purpose for an old test.
Nuclear ?-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.
Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes.
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
Slow and steady wins the race: precision medicine for low risk endometrial cancer.
Loss of CD73 shifts transforming growth factor-?1 (TGF-?1) from tumor suppressor to promoter in endometrial cancer.
Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy.
Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis.
Low grade endometrioid endometrial cancer: complexities beyond p53abn.
Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer.
Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival.
Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.